Synaptogenix Accounts Payable vs Total Current Liabilities Analysis

SNPX Stock

USD 2.72 0.01 0.37%

Synaptogenix financial indicator trend analysis is much more than just breaking down Synaptogenix prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Synaptogenix is a good investment. Please check the relationship between Synaptogenix Accounts Payable and its Total Current Liabilities accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synaptogenix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.

Accounts Payable vs Total Current Liabilities

Accounts Payable vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Synaptogenix Accounts Payable account and Total Current Liabilities. At this time, the significance of the direction appears to have weak relationship.

The correlation between Synaptogenix's Accounts Payable and Total Current Liabilities is 0.33. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Synaptogenix, assuming nothing else is changed. The correlation between historical values of Synaptogenix's Accounts Payable and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Synaptogenix are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Accounts Payable i.e., Synaptogenix's Accounts Payable and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.33

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Synaptogenix obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Synaptogenix are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Total Current Liabilities

Total Current Liabilities is an item on Synaptogenix balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Synaptogenix are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most indicators from Synaptogenix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Synaptogenix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synaptogenix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.At this time, Synaptogenix's Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 3.22 in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.

	2021	2022	2023	2024 (projected)
Interest Income	7.1K	335.0K	1.5M	1.6M
Net Interest Income	7.1K	335.0K	1.5M	1.6M

Interest Income Net Interest Income

Synaptogenix fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Net Working Capital	Common Stock	Property Plant Equipment	Net Receivables	Other Liab	Other Assets
Total Assets		0.52	0.54	0.98	0.95	-0.48	-1.0	0.48	0.19	1.0	0.41	1.0	-0.08	0.69	0.53	-0.32	0.68	0.98	0.49	1.0	0.99	0.06	-0.45	-0.37	-0.37	-0.37
Other Current Liab	0.52		0.98	0.38	0.59	-0.95	-0.53	0.51	0.11	0.48	0.99	0.51	-0.83	0.58	-0.12	-0.53	0.84	0.39	0.96	0.51	0.42	0.44	-0.88	-0.94	-0.94	-0.94
Total Current Liabilities	0.54	0.98		0.4	0.59	-0.91	-0.54	0.67	0.33	0.5	0.93	0.52	-0.88	0.69	0.06	-0.69	0.87	0.41	0.95	0.53	0.44	0.28	-0.85	-0.89	-0.89	-0.89
Total Stockholder Equity	0.98	0.38	0.4		0.9	-0.38	-0.99	0.39	0.16	0.99	0.28	0.98	0.08	0.6	0.56	-0.22	0.53	1.0	0.34	0.99	1.0	-0.03	-0.39	-0.27	-0.27	-0.27
Net Tangible Assets	0.95	0.59	0.59	0.9		-0.53	-0.93	0.41	0.08	0.94	0.51	0.95	-0.17	0.59	0.39	-0.25	0.76	0.91	0.62	0.95	0.92	0.32	-0.46	-0.38	-0.38	-0.38
Property Plant And Equipment Net	-0.48	-0.95	-0.91	-0.38	-0.53		0.51	-0.37	-0.08	-0.45	-0.95	-0.47	0.75	-0.41	0.17	0.4	-0.65	-0.41	-0.85	-0.47	-0.4	-0.41	0.98	0.96	0.96	0.96
Net Debt	-1.0	-0.53	-0.54	-0.99	-0.93	0.51		-0.46	-0.17	-1.0	-0.43	-1.0	0.08	-0.68	-0.5	0.31	-0.65	-0.98	-0.48	-1.0	-0.99	-0.04	0.5	0.42	0.42	0.42
Retained Earnings	0.48	0.51	0.67	0.39	0.41	-0.37	-0.46		0.84	0.45	0.38	0.46	-0.62	0.93	0.69	-0.98	0.73	0.37	0.54	0.48	0.41	-0.38	-0.34	-0.35	-0.35	-0.35
Accounts Payable	0.19	0.11	0.33	0.16	0.08	-0.08	-0.17	0.84		0.17	-0.02	0.16	-0.4	0.64	0.78	-0.83	0.28	0.16	0.12	0.19	0.15	-0.68	-0.13	-0.03	-0.03	-0.03
Cash	1.0	0.48	0.5	0.99	0.94	-0.45	-1.0	0.45	0.17		0.37	1.0	-0.03	0.67	0.54	-0.29	0.64	0.99	0.45	1.0	1.0	0.04	-0.43	-0.34	-0.34	-0.34
Non Current Assets Total	0.41	0.99	0.93	0.28	0.51	-0.95	-0.43	0.38	-0.02	0.37		0.41	-0.82	0.45	-0.28	-0.42	0.77	0.29	0.95	0.4	0.32	0.54	-0.87	-0.95	-0.95	-0.95
Cash And Short Term Investments	1.0	0.51	0.52	0.98	0.95	-0.47	-1.0	0.46	0.16	1.0	0.41		-0.06	0.67	0.52	-0.3	0.67	0.98	0.49	1.0	0.99	0.07	-0.45	-0.36	-0.36	-0.36
Common Stock Shares Outstanding	-0.08	-0.83	-0.88	0.08	-0.17	0.75	0.08	-0.62	-0.4	-0.03	-0.82	-0.06		-0.5	0.11	0.72	-0.68	0.07	-0.83	-0.07	0.04	-0.22	0.68	0.77	0.77	0.77
Non Current Liabilities Total	0.69	0.58	0.69	0.6	0.59	-0.41	-0.68	0.93	0.64	0.67	0.45	0.67	-0.5		0.66	-0.88	0.8	0.57	0.58	0.69	0.63	-0.3	-0.38	-0.43	-0.43	-0.43
Other Current Assets	0.53	-0.12	0.06	0.56	0.39	0.17	-0.5	0.69	0.78	0.54	-0.28	0.52	0.11	0.66		-0.56	0.25	0.54	-0.08	0.54	0.55	-0.69	0.14	0.27	0.27	0.27
Other Stockholder Equity	-0.32	-0.53	-0.69	-0.22	-0.25	0.4	0.31	-0.98	-0.83	-0.29	-0.42	-0.3	0.72	-0.88	-0.56		-0.67	-0.19	-0.55	-0.32	-0.24	0.38	0.38	0.42	0.42	0.42
Total Liab	0.68	0.84	0.87	0.53	0.76	-0.65	-0.65	0.73	0.28	0.64	0.77	0.67	-0.68	0.8	0.25	-0.67		0.53	0.91	0.67	0.58	0.32	-0.53	-0.61	-0.61	-0.61
Net Invested Capital	0.98	0.39	0.41	1.0	0.91	-0.41	-0.98	0.37	0.16	0.99	0.29	0.98	0.07	0.57	0.54	-0.19	0.53		0.35	0.98	0.99	0.0	-0.41	-0.28	-0.28	-0.28
Property Plant And Equipment Gross	0.49	0.96	0.95	0.34	0.62	-0.85	-0.48	0.54	0.12	0.45	0.95	0.49	-0.83	0.58	-0.08	-0.55	0.91	0.35		0.48	0.38	0.53	-0.73	-0.82	-0.82	-0.82
Total Current Assets	1.0	0.51	0.53	0.99	0.95	-0.47	-1.0	0.48	0.19	1.0	0.4	1.0	-0.07	0.69	0.54	-0.32	0.67	0.98	0.48		0.99	0.05	-0.45	-0.36	-0.36	-0.36
Net Working Capital	0.99	0.42	0.44	1.0	0.92	-0.4	-0.99	0.41	0.15	1.0	0.32	0.99	0.04	0.63	0.55	-0.24	0.58	0.99	0.38	0.99		0.0	-0.4	-0.3	-0.3	-0.3
Common Stock	0.06	0.44	0.28	-0.03	0.32	-0.41	-0.04	-0.38	-0.68	0.04	0.54	0.07	-0.22	-0.3	-0.69	0.38	0.32	0.0	0.53	0.05	0.0		-0.27	-0.35	-0.35	-0.35
Property Plant Equipment	-0.45	-0.88	-0.85	-0.39	-0.46	0.98	0.5	-0.34	-0.13	-0.43	-0.87	-0.45	0.68	-0.38	0.14	0.38	-0.53	-0.41	-0.73	-0.45	-0.4	-0.27		0.95	0.95	0.95
Net Receivables	-0.37	-0.94	-0.89	-0.27	-0.38	0.96	0.42	-0.35	-0.03	-0.34	-0.95	-0.36	0.77	-0.43	0.27	0.42	-0.61	-0.28	-0.82	-0.36	-0.3	-0.35	0.95		1.0	1.0
Other Liab	-0.37	-0.94	-0.89	-0.27	-0.38	0.96	0.42	-0.35	-0.03	-0.34	-0.95	-0.36	0.77	-0.43	0.27	0.42	-0.61	-0.28	-0.82	-0.36	-0.3	-0.35	0.95	1.0		1.0
Other Assets	-0.37	-0.94	-0.89	-0.27	-0.38	0.96	0.42	-0.35	-0.03	-0.34	-0.95	-0.36	0.77	-0.43	0.27	0.42	-0.61	-0.28	-0.82	-0.36	-0.3	-0.35	0.95	1.0	1.0

Click cells to compare fundamentals

Synaptogenix Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Synaptogenix Stock Analysis

When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Synaptogenix Accounts Payable vs Total Current Liabilities Analysis

Accounts Payable vs Total Current Liabilities

Accounts Payable vs Total Current Liabilities Correlation Analysis

Correlation Coefficient

Accounts Payable

Total Current Liabilities

Synaptogenix fundamental ratios Correlations

Synaptogenix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Synaptogenix Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Working Capital	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash

Total Current Assets	- 1.0	Net Debt
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Net Debt	- 1.0	Total Assets
Net Working Capital	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity